— Know what they know.
Not Investment Advice

ACCD NASDAQ

Accolade, Inc.
1W: +0.4% 1M: +0.9% 3M: +100.6% 1Y: -23.6% 3Y: -62.8%
$7.02
Last traded 2025-04-08 — delisted
NASDAQ · Healthcare · Medical - Healthcare Information Services · $575.6M mcap · 64M float · 2.30% daily turnover · Short 42% of daily vol

Cash Flow Trends

Operating Cash Flow
-$16M +60.3% ▲
Capital Expenditures
$12M -72.7% ▼
5Y CAGR: +32.0%
Free Cash Flow
-$29M +40.2% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$135M -202.4% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$51M-$51M-$123M-$460M-$100M
Depreciation & Amort.$9M$8M$43M$46M$45M
Stock-Based Comp.$12M$10M$73M$73M$61M
Change in Working Capital-$5M$4M-$8M-$1M-$20M
Other Non-Cash Items$2M$4M-$41M$305M-$3M
Operating Cash Flow-$34M-$25M-$62M-$41M-$16M
— Investing Activities —
Capital Expenditures-$3M-$2M-$4M-$7M-$5M
Acquisitions (Net)-$206K-$58K-$260M$0$0
Investment Purchases$0$0-$100M$0-$51M
Investment Sales$0$0$100M$0$0
Other Investing$0-$58K-$1M-$5M-$8M
Investing Cash Flow-$4M-$2M-$264M-$7M-$64M
— Financing Activities —
Net Debt Issuance$2M-$23M$288M$0-$66M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$7M$451M-$30M$3M-$355K
Financing Cash Flow$28M$428M$258M$3M-$56M
Net Change in Cash-$10M$401M-$68M-$45M-$135M
Cash End of Period$33M$434M$366M$321M$186M
Free Cash Flow-$38M-$28M-$66M-$48M-$29M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms